REFERFNCES

  1. Meisterer A. Glutathione. Ann Rev Biochem 52:711-60, 1983.
  2. Kaplowitz N, Aw T, Ookhtens M. The regulation of hepatic glutathione. Ann Rev Pharmacol Toxicol 25:715-44, 1985.
  3. Witchi A, Reddy S, Stofer B, Lauterberg B. The systemic availability of oral glutatlilone Eur J Clin Pharmacol 43:667-9, 1992
  4. Meister A. New aspects of glutathione biochemistry and transport, selective alteration of glutathione metabolism. Nutr Rev 42:397-410, 1984.
  5. Bray T, Taylor C. Enhancement of tissue glutathione for antioxidant and immune functions in malnutrition. Biochem Pharmacol
  6. 47:2113-23, 1994.
  7. Lomaestro B, Malone M. Glutathione in health and disease: Pharmacotheraputic Issues. Ann Pharmacother 29:1263-73, 1995
  8. Bounous G, Gold P. The biological activity of undenatured whey proteins: The role of glutathione. Clin Invest Med 14:296-309, 1991.
  9. Bounous G, Kongshavn P. Influence of dietary whey proteins on the immune system of mice. J Nutr 112:1747-55, 1982.
  10. Bounous G, letourneau L, Kongshavn P. Influence of dietary protein type on the immune system of mice.J Nutr 113:1415-21, 1983.
  11. Bounous G, Kongshavn P. Influence of protein type in nutritionally adequate diets on the development of immunity. Absorption and utilization' of amino acids 2:219-32 1989.
  12. Bounous G, Batist G, Gold P, Immuno-enhancing property of dietary whey protein in mice: Role of glutathione. (Clin Invest Med 12:154-61, 1989.
  13. Bounous G, Shenouda N, Kongshavn P, Osmond. D. Mechanism of altered B-cell response induced by changes in dietary protein type in mice. J Nutr 115:1409-17,1985.
  14. Bounous G, Papenburg R, Kongshavn P, Gold P, et al. Dietary whey protein inhibits the development of DMH-induced malignancy. Clin Invest Med 11:213-17, 1988.
  15. Bounous G, Gervais F; Amer V, Batist G, et al. The influence of dietary whey protein on tissue glutathione and the diseases of aging. (Clin Invest Med 12:343-9, 1989.
  16. Baruchel S, Viau g, Olivier R, Bounous G, Wainberg MA. Nutriceutical modulation of glutathione with a humanized native milk serum protein isolate Immunocal: Application in AIDS and cancer. In: Oxidative stress in Cancer AIDS and Neurodegenerative Diseases. Ed.; Montagnier L, Olivier R, Pasquier C. Pub.; Marcel Dekker Inc. New York, 1996.
  17. Kennedy R, Konok G, Bounous G, Baruchel S, Lee T. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: A phase I-Il clinical study. Anticancer Research 15:2643-50, 1995.
  18. Baruchel S, Bounous G, Gold P. Place for an antioxidant therapy in HIV infection. Oxidative stress, Cell activation and viral infection, 311-21,1994.
  19. Bounous G, Baruchel S, Falutz J, Gold P. Whey proteins as a food supplement in HIV-seropositive individuals. Clin Invest Med. 16:3; 204-209.
  20. Baruchel S, Viau G. In-vitro selective modulation of cellular glutathione by a humanized native milk protein isolate in normal cells and rat mammary carcinoma model. Auticancer Research. 16:1095-1100,1996.
  21. Bounous G, Batist G, Gold P. Whey proteins in cancer prevention. Cancer Letters. 57:91-94, 1991.
  22. Watanabe A, Higuchi K, Yasumura S, Shimizu Y, Kondo Y, Kohri H. Nutritional modulation of glutathione level and cellular immunity in chronic hepatitis B and C. Hepatology 24:597A, 1996.
  23. Lothian B, Grey V, Kimoff RJ, Lands LC. Treatment of obstructive airway disease with a cysteine donor protein supplement: A case report. Chest 117:914-916, 2000.
  24. Cross CE, Halliwell B, Borish ET; et al. Oxygen radicals and human disease. Annals of Internal Medicine 107:526-545, 1987.
  25. Lands LC, Grey VL, Smountas AA. Effect of supplementation with a cysteine donor on muscular performance. J. Appl. Physiol. 87:1381-1385,1999.
  26. Short S, Merkel BJ, Caffrey R, McCoy KL. Defective antigen processing correlates with a low level of intracellular glutathione. Eur. J:Immunol. 26(12):3015-3020. 1996.
  27. Macho A, Hirsch T, Marzo I, Marchetti P, Dallaporta B, Susin SA, Zamzami N, Kroemer C. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J. Immunol 158(10):4612-46~9, 1997.
  28. Gmunder H, Eck HP Benninghoff B, Roth S, Droge W. Macrophages regulate intracellular glutathione levels of lymphocytes. Evidence for an immunoregulatory role of cysteine. Cell. Immunol. 129(1):32-46, 1990.
  29. Kranich 0, Dringen R, Sandberg M, Harnprecht B. Utilization of cysteine and cysteine precursors for the synthesis of glutathione in astroglial cultures: preference for cystine. Glia. 22(1):11-18, 1998.
  30. Droge W, Holm E. Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction. FASEB J: 11(13):1077-1089, 1997.
Click to Print This Page


2003 Nutritionadvisor, Inc
DISCLAIMER: We make no medical claims regarding our supplements. Our nutritional supplements are not intended to treat or cure any disease. Please contact your physician before embarking on any weight loss or exercise program.